Results 151 - 153 of 153

An integrated approach to monitoring the safety of medicines that includes both active surveillance and spontaneous reporting is essential to a well-functioning pharmaceutical sector. Active surveillance is particularly important to support the introduction of new essential medicines in low-and middle-income countries, where regulatory systems are often still developing and need support.

National governments must effectively register and track pharmaceutical products to ensure that they are readily available and safe.

This page provides a technical brief for the QuanTB software.QuanTB is an electronic quantification and early warning system designed to improve procurement processes, ordering, and supply planning for tuberculosis (TB) treatment.